Pure Global
NCT05152862

Improve Screening Criteria for Retinopathy of Prematurity in Two French Center

Evaluation of the Criteria and Modalities of Screening for Retinopathy of Prematurity in Two French Tertiary NICU : is a Simplification Possible ?
Centre Hospitalier Sud Francilien·ClinicalTrials.gov·procedureCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Retinopathy of Prematurity
Drug/Device/Intervention
Laser
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Centre Hospitalier Sud Francilien
Location
Corbeil-Essonnes, France
Timeline & enrollment
Phase
N/A
Start date
Mar 21, 2022
End date
Jun 16, 2022
Enrollment
886 participants
Primary outcome

Number of infants with type 1 or 2 ROP found at routine screening.

Summary

The aim of the study is to assess whether a delay of the first examination can be safely
 considered in French population. Secondary objectives are to describe retinopathy of
 prematurity (ROP) in a population of premature from two French tertiary NICU and to identify
 co-morbidities associated with the development of severe ROP.

ICD-10 classifications
Retinopathy of prematurityOther proliferative retinopathyBackground retinopathy and retinal vascular changesDiabetic retinopathyRetinal disorder, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05152862
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05152862 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Sud Francilien and is currently Completed. The study focuses on Retinopathy of Prematurity. Target enrollment is 886 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.